Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

4929 Pages (Click to Jump) V  « < 249 250 251 252 253 254 255 > »    
Reply to this topic

Fortescue Bullro...
post Posted: Oct 9 2019, 04:30 PM
  Quote Post

Posts: 126
Thanks: 153

In Reply To: Fortescue Bullrout's post @ Oct 9 2019, 04:27 PM

And my congratulations and sincere thanks to all here. For a pickup band, we make some fine music.
To PW and all at Clinuvel, simply, well done.

Said 'Thanks' for this post: IntiRaymi  PunkassDerm  
Fortescue Bullro...
post Posted: Oct 9 2019, 04:27 PM
  Quote Post

Posts: 126
Thanks: 153

Topicals and sunscreens: a number of product lines, Very secretive approach, we won’t educate our competitors. “The novelty is holding up” .To clinical trials within a year.

Said 'Thanks' for this post: Dr Wally  IntiRaymi  Lisa0825  Clinhope  
post Posted: Oct 9 2019, 04:19 PM
  Quote Post

Posts: 761
Thanks: 1435

In Reply To: NewToCli's post @ Oct 9 2019, 03:31 PM

I think everything important has already been posted smile.gif

post Posted: Oct 9 2019, 04:17 PM
  Quote Post

Posts: 62
Thanks: 33

Champagne cracked let's just enjoy the day yeeehhaaah

Said 'Thanks' for this post: royco  
post Posted: Oct 9 2019, 04:13 PM
  Quote Post

Posts: 639
Thanks: 2287

In Reply To: Johnny H's post @ Oct 9 2019, 04:10 PM

Nor mine.

Don't like that "selected questions only" approach.
Despite that, today was still a good day.

Dr Wolgen is a magician.
His end game for Scenesse will impress, or even amaze.
En route, along with glimmers of truth, there will be distractions, illusions, sleight of hand and misdirection.
Enjoy the ride.

Said 'Thanks' for this post: Johnny H  PunkassDerm  
post Posted: Oct 9 2019, 04:13 PM
  Quote Post

Posts: 746
Thanks: 704

VP still at concept stage. Vitiligo progression sounds more promising with FDA discussions to follow concerning clinical program.

VP still up in the air. I'm betting this may change to another indication. I put forward a question about off label use, it got thrown in the bin. After today's rally, I forgive you PW.

Said 'Thanks' for this post: IntiRaymi

Share Cafe Sentifi Top themes and market attention on:

Johnny H
post Posted: Oct 9 2019, 04:10 PM
  Quote Post

Posts: 876
Thanks: 1665

I guess they didn't want to answer my question.

Clinuvel until my bowels release for the last time.

Said 'Thanks' for this post: macgyver  
post Posted: Oct 9 2019, 04:09 PM
  Quote Post

Posts: 587
Thanks: 2454

No mentioning of the VP trial that was supposed to begin last spring. But they are working on a strategy.

Said 'Thanks' for this post: IntiRaymi  
Dr Wally
post Posted: Oct 9 2019, 04:08 PM
  Quote Post

Posts: 676
Thanks: 740

Jaye- what’s next? Hahaha! 🤣🤣🥳🥳🥳

After today’s action I’d say 1 or two strong alcoholic beverages. Woohoo!

Onwards and upwards doesn’t quite do the situation justice. 😎

Serious question: what do you guys (that weren’t too keen) think of our management now?

The Clinuvel information and communication age has begun.

“” The discovery of the endogenous melanocortin agonists in the 1950s have resulted in sixty years of melanocortin ligand research.””

The never ending quest to have Afamelanotide (peptide) (SEMI) accepted for its potent ability to stimulate a natural photoprotective,cancer preventative, therapeutic “tan” was (SEMI) accomplished in 2019.

Regulator ignorance, bias, and stubborn resistance to Scenesse are the primary reasons behind this glacial journey. The evidence should be clear to all by now.

Said 'Thanks' for this post: Billy Boots  PunkassDerm  
post Posted: Oct 9 2019, 04:08 PM
  Quote Post

Posts: 246
Thanks: 377

Priority review will be requested in Australia.
But FDA approval doesnt directly impact the australia review process.

But w.r.t. Japan:
They are right now developing a strategy to moving into Japan.

Said 'Thanks' for this post: PortugueseMan  IntiRaymi  

4929 Pages (Click to Jump) V  « < 249 250 251 252 253 254 255 > » 

Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.